XML 102 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated statements of operations and comprehensive income / (loss) (USD $)
 12 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Net revenues $ 205,670,946 $ 218,952,724
Cost of revenues (204,197,751) (192,648,690)
Gross profit 1,473,195 26,304,034
Operating expenses:    
Research and development expenses (5,759,072) (7,287,214)
Sales and marketing expenses (8,488,889) (8,541,782)
General and administrative expenses (40,008,940) (18,130,183)
Impairment charge (3,918,959) (6,517,344)
Total operating expenses (58,175,860) (40,476,523)
Operating loss (56,702,665) (14,172,489)
Finance costs, net (11,265,990) (10,828,983)
Government grant income 5,353,554 1,453,727
Other income / (expense) (798,528) 312,501
Loss before income taxes (63,413,629) (23,235,244)
Income taxes expense (2,393,766) (1,302,120)
Net loss (65,807,395) (24,537,364)
Other comprehensive income    
- Foreign currency translation adjustment 1,525,041 7,794,274
Comprehensive loss $ (64,282,354) $ (16,743,090)
EPS before one-for-five reverse stock split [Member]
    
Net loss per share:    
- Basic (1.04) (0.39)
- Diluted (1.04) (0.39)
Weighted average number of ordinary shares:    
- Basic 63,095,246 62,945,047
- Diluted 63,095,246 62,945,047
EPS after one-for-five reverse stock split [Member]
    
Net loss per share:    
- Basic (5.21) (1.95)
- Diluted (5.21) (1.95)
Weighted average number of ordinary shares:    
- Basic 12,619,063 12,589,009
- Diluted 12,619,063 12,589,009